Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Literature
1.
Sargın G, Yavasoglu I, Doger FK, Kadikoylu G, Bolaman Z. A coincidence of renal cell carcinoma and hematological malignancies. Med Oncol. 2012;29:3335–8.PubMedCrossRef
2.
Nishikubo CY, Kunkel LA, Figlin R, Belldegrun A, Rosen P, Elashoff R, Wang H, Territo MC. An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients. Cancer. 1996;78:2421–6.PubMedCrossRef
3.
Shah IA, Haddad FS, Gani OS, Alfsen CC. An association between renal cell carcinoma and lymphoid malignancies: a case series of eight patients. Cancer. 1997;80:1005–7.PubMedCrossRef
4.
Tihan T, Filippa DA. Coexistence of renal cell carcinoma and malignant lymphoma. A causal relationship or coincidental occurrence? Cancer. 1996;77:2325–31.PubMedCrossRef
5.
Prosvic P, Dulícek P, Odrázka K, Navrátilová J, Morávek P, Macek P, Veselský Z. Asynchronous occurrence of three neoplastic diseases: chronic B-cell lymphatic leukemia, renal carcinoma and prostatic adenocarcinoma. Rozhl Chir. 2003;82:583–6.PubMed
6.
Kunthur A, Wiernik PH, Dutcher JP. Renal parenchymal tumors and lymphoma in the same patient: case series and review of the literature. Am J Hematol. 2006;81:271–80.PubMedCrossRef
7.
Thway K, Freeman A, Woodhouse CR, Fisher C. Epithelial-stromal tumor of seminal vesicle in a patient with chromophobe renal cell carcinoma and small lymphocytic lymphoma. Ann Diagn Pathol. 2008;12:433–9.PubMedCrossRef
8.
Deeb R, Zhang Z, Ghanem T. Metastatic renal cell carcinoma to the parotid gland in the setting of chronic lymphocytic leukemia. Case Rep Med. 2012;2012:265708. doi:10.​1155/​2012/​265708.
9.
Schlegel PJ, Samlowski WE, Ward JH. Autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia and renal cell carcinoma after treatment with high-dose intravenous bolus interleukin-2. J Immunother. 2000;23:507–8.PubMedCrossRef
Metadata
Title
Renal cell carcinoma and chronic lymphocytic leukemia
Authors
Gokhan Sargin
Irfan Yavasoglu
Publication date
01-06-2013
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2013
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-013-0547-2

Other articles of this Issue 2/2013

Medical Oncology 2/2013 Go to the issue

Original Paper

Association of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer risk

Original Paper

Association between single nucleotide polymorphisms of the transforming growth factor-beta1 gene and overall survival in unresectable locally advanced non-small-cell lung cancer patients treated with radio(chemo)therapy in a Chinese population

Original Paper

High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients

Original Paper

Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART)

Letter to the Editor

“Combined” small cell and “pure” small cell lung cancer: is there a clinical difference?

Original Paper

Treatment of peripheral T Cell Lymphoma with an intensive protocol ACEP (Adriamycin, Cyclophosphamide, Etoposide and Prednisolone) and Ifosfamide showing an important response and overall survival rates
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits